Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion
暂无分享,去创建一个
K. Holmes | M. Frana | L. Sturman | J. Behnke | M F Frana | J N Behnke | L S Sturman | K V Holmes | F. Mark | Frana | N. James | Behnke | '. L. S. Sturman | V. Kathryn | '. Holmes
[1] K. Holmes,et al. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments , 1985, Journal of virology.
[2] G. Appleyard,et al. Inhibition of the growth of human coronavirus 229E by leupeptin. , 1985, The Journal of general virology.
[3] S. Cheley,et al. Fusion resistance and decreased infectability as major host cell determinants of coronavirus persistence , 1983, Virology.
[4] A. Osterhaus,et al. Temperature-sensitive mutants of mouse hepatitis virus strain A59: Isolation, characterization and neuropathogenic properties , 1983, Virology.
[5] H. Klenk,et al. Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin. , 1982, The EMBO journal.
[6] D. Stern,et al. Coronavirus proteins: biogenesis of avian infectious bronchitis virus virion proteins , 1982, Journal of virology.
[7] R. Knobler,et al. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion , 1982, Virology.
[8] K. Holmes,et al. Cell tropism and expression of mouse hepatitis viruses (MHV) in mouse spinal cord cultures☆ , 1982, Virology.
[9] V. ter meulen,et al. The structure and replication of coronaviruses. , 1982, Current Topics in Microbiology and Immunology.
[10] V. ter meulen,et al. The biology and pathogenesis of coronaviruses. , 1982, Current topics in microbiology and immunology.
[11] H. Klenk,et al. Coronavirus glycoprotein E1, a new type of viral glycoprotein☆ , 1981, Journal of Molecular Biology.
[12] H. Klenk,et al. Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage. , 1981, Virology.
[13] K. Holmes,et al. Tunicamycin resistant glycosylation of a coronavirus glycoprotein: Demonstration of a novel type of viral glycoprotein , 1981, Virology.
[14] V. Morris,et al. RNA and polypeptide homology among murine coronaviruses , 1981, Virology.
[15] J. Rothman,et al. Early and late functions associated with the Golgi apparatus reside in distinct compartments. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[16] H. Yoshikura,et al. Role of protease in mouse hepatitis virus-induced cell fusion Studies with a cold-sensitive mutant isolated from a persistent infection , 1981, Virology.
[17] K. Kawasaki,et al. Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5.2. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[18] Marian C. Horzinek,et al. Translation of three mouse hepatitis virus strain A59 subgenomic RNAs in Xenopus laevis oocytes , 1981, Journal of virology.
[19] D. Cavanagh. Structural polypeptides of coronavirus IBV. , 1981, The Journal of general virology.
[20] R. Rott,et al. Enhancement of plaque formation and cell fusion of an enteropathogenic coronavirus by trypsin treatment , 1981, Infection and immunity.
[21] V. ter meulen,et al. Coronavirus JHM: intracellular protein synthesis. , 1981, The Journal of general virology.
[22] Marian C. Horzinek,et al. Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59) , 1981, Virology.
[23] K. Holmes,et al. Analysis of the functions of coronavirus glycoproteins by differential inhibition of synthesis with tunicamycin. , 1981, Advances in experimental medicine and biology.
[24] F. Bang. The use of a genetically incompatible combination of host and virus (MHV) for the study of mechanisms of host resistance. , 1981, Advances in experimental medicine and biology.
[25] H. Klenk,et al. Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicity. , 1980, The Journal of general virology.
[26] V. ter meulen,et al. Coronavirus JHM: Cell-Free Synthesis of Structural Protein p60 , 1980, Journal of virology.
[27] K. Holmes,et al. Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid , 1980, Journal of virology.
[28] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[29] H. Klenk,et al. The structure of the hemagglutinin, a determinant for the pathogenicity of influenza viruses. , 1979, Virology.
[30] J. Robb,et al. Pathogenic murine coronaviruses I. Characterization of biological behavior in vitro and virus-specific intracellular RNA of strongly neurotropic JHMV and weakly neurotropic A59V viruses , 1979, Virology.
[31] W. Flintoff,et al. In vivo and in vitro models of demyelinating diseases: Tropism of the JHM strain of murine hepatitis virus for cells of glial origin , 1977, Cell.
[32] H. Klenk,et al. Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. , 1976, Virology.
[33] H Umezawa,et al. Structures and activities of protease inhibitors of microbial origin. , 1976, Methods in enzymology.
[34] A. Scheid,et al. Protease activation mutants of sendai virus. Activation of biological properties by specific proteases. , 1976, Virology.
[35] H. Klenk,et al. Activation of influenza A viruses by trypsin treatment. , 1975, Virology.
[36] P. Choppin,et al. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. , 1975, Virology.
[37] K. Mcintosh,et al. Coronaviruses: a comparative review. , 1974 .
[38] R. Compans,et al. Proteolytic cleavage of the hemagglutinin polypeptide of influenza virus. Function of the uncleaved polypeptide HA. , 1973, Virology.
[39] L. Sturman,et al. Enhanced Growth of a Murine Coronavirus in Transformed Mouse Cells , 1972, Infection and immunity.
[40] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[41] R. Chanock,et al. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. , 1967, Proceedings of the National Academy of Sciences of the United States of America.
[42] P. Choppin,et al. ON THE ROLE OF THE RESPONSE OF THE CELL MEMBRANE IN DETERMINING VIRUS VIRULENCE , 1966, The Journal of experimental medicine.
[43] J. Hartley,et al. Tissue Culture Cytopathic and Plaque Assays for Mouse Hepatitis Viruses , 1963, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[44] F. Bang,et al. MOUSE MACROPHAGES AS HOST CELLS FOR THE MOUSE HEPATITIS VIRUS AND THE GENETIC BASIS OF THEIR SUSCEPTIBILITY. , 1960, Proceedings of the National Academy of Sciences of the United States of America.